Stock 3902 MEDICAL DATA VISION CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medical Data Vision Co., Ltd.

Equities

3902

JP3921250001

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
585 JPY -0.68% Intraday chart for Medical Data Vision Co., Ltd. +1.21% -10.69%
Feb. 13 Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024 CI
Feb. 13 Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 35,343 111,812 48,590 34,301 25,019 22,345 - -
Enterprise Value (EV) 1 32,399 108,618 45,369 32,037 21,801 18,664 18,077 17,393
P/E ratio 63.8 x 160 x 44.9 x 39.4 x 25.6 x 22.9 x 19.1 x 17.4 x
Yield - 0.13% 0.45% 0.67% 0.99% 1.11% 1.15% 1.2%
Capitalization / Revenue 8.78 x 24.4 x 8.57 x 5.62 x 3.9 x 2.89 x 2.55 x 2.3 x
EV / Revenue 8.05 x 23.7 x 8 x 5.25 x 3.4 x 2.41 x 2.06 x 1.79 x
EV / EBITDA 34.6 x 83.2 x 26.2 x 16.8 x - 11.8 x 9.69 x 8.56 x
EV / FCF 27 x 132 x 43 x 37.3 x 14 x 32.1 x 18.8 x 14.7 x
FCF Yield 3.7% 0.76% 2.33% 2.68% 7.14% 3.12% 5.32% 6.8%
Price to Book 8.86 x 27.3 x 11.7 x 9.76 x 5.89 x 4.49 x 3.79 x 3.24 x
Nbr of stocks (in thousands) 40,026 39,426 38,997 38,197 38,197 38,197 - -
Reference price 2 883.0 2,836 1,246 898.0 655.0 585.0 585.0 585.0
Announcement Date 2/10/20 2/8/21 2/14/22 2/13/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,026 4,579 5,672 6,104 6,419 7,740 8,770 9,730
EBITDA 1 936.3 1,305 1,730 1,908 - 1,582 1,866 2,032
EBIT 1 809 1,146 1,594 1,758 1,770 1,500 1,785 1,950
Operating Margin 20.09% 25.03% 28.1% 28.8% 27.57% 19.38% 20.35% 20.04%
Earnings before Tax (EBT) 1 657 1,076 1,591 1,426 1,567 1,441 1,726 1,891
Net income 1 554 700 1,087 870 979 975 1,170 1,280
Net margin 13.76% 15.29% 19.16% 14.25% 15.25% 12.6% 13.34% 13.16%
EPS 2 13.85 17.72 27.74 22.77 25.63 25.55 30.65 33.55
Free Cash Flow 1 1,198 821.8 1,056 858 1,557 582 962 1,182
FCF margin 29.76% 17.95% 18.61% 14.06% 24.26% 7.52% 10.97% 12.15%
FCF Conversion (EBITDA) 127.96% 62.96% 61.03% 44.97% - 36.8% 51.54% 58.18%
FCF Conversion (Net income) 216.25% 117.4% 97.12% 98.62% 159.04% 59.69% 82.22% 92.34%
Dividend per Share 2 - 3.600 5.600 6.000 6.500 6.500 6.750 7.000
Announcement Date 2/10/20 2/8/21 2/14/22 2/13/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 2,240 2,046 2,533 2,635 1,317 1,720 3,037 1,511 1,345 2,856 1,471 1,777 3,248 1,559 1,443 3,002 1,485 1,842 1,788 3,520 1,815 2,295
EBITDA - - - - - - - - - - - - - - - - - - - - - -
EBIT 1 539 475 671 720 317 557 874 470 315 785 383 590 973 423 296 719 392 65.5 -84 40 493 1,026
Operating Margin 24.06% 23.22% 26.49% 27.32% 24.07% 32.38% 28.78% 31.11% 23.42% 27.49% 26.04% 33.2% 29.96% 27.13% 20.51% 23.95% 26.4% 3.55% -4.7% 1.14% 27.16% 44.68%
Earnings before Tax (EBT) 1 387 476 600 718 317 556 873 461 315 776 383 267 650 424 275 699 347 59 -90.5 - 486.5 1,014
Net income 1 381 319 381 484 215 388 603 313 209 522 254 94 348 275 170 445 214 39 -61 - 328 689.5
Net margin 17.01% 15.59% 15.04% 18.37% 16.32% 22.56% 19.86% 20.71% 15.54% 18.28% 17.27% 5.29% 10.71% 17.64% 11.78% 14.82% 14.41% 2.12% -3.41% - 18.07% 30.04%
EPS 9.520 8.060 - 12.32 5.500 9.920 15.42 8.170 - 13.65 6.650 - - 7.210 - 11.66 5.610 - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - - - -
Announcement Date 2/10/20 8/11/20 2/8/21 8/10/21 11/8/21 2/14/22 2/14/22 5/12/22 8/8/22 8/8/22 11/14/22 2/13/23 2/13/23 5/11/23 8/10/23 8/10/23 11/13/23 - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2,944 3,194 3,221 2,264 3,218 3,681 4,268 4,952
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 1,198 822 1,056 858 1,557 582 962 1,182
ROE (net income / shareholders' equity) 15.3% 17.3% 26.3% 24.2% 25.2% 21.2% 21.5% 20%
ROA (Net income/ Total Assets) 18.2% 22.4% 29.3% 33.6% 30.6% 20.1% 20.9% 21.4%
Assets 1 3,036 3,131 3,706 2,593 3,201 4,851 5,598 5,981
Book Value Per Share 2 99.70 104.0 107.0 92.00 111.0 130.0 154.0 181.0
Cash Flow per Share 17.00 19.90 29.40 24.40 26.90 - - -
Capex 1 77.1 27.1 24 52 59 40 40 40
Capex / Sales 1.92% 0.59% 0.42% 0.85% 0.92% 0.52% 0.46% 0.41%
Announcement Date 2/10/20 2/8/21 2/14/22 2/13/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Medical Data Vision Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
585 JPY
Average target price
710 JPY
Spread / Average Target
+21.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
MEDICAL DATA VISION CO., LTD. Stock Medical Data Vision Co., Ltd.
-10.69% 142M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+14.14% 7.45B
SECTRA AB Stock Sectra AB
+22.93% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.17B
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. 3902 Stock
  4. Financials Medical Data Vision Co., Ltd.